Lipid Nanotech LLC was established after winning the 2012 Innolevation competition at Florida State University sponsored by the Jim Moran Institute for Global Entrepreneurship and Florida State University College of Business. We are headquartered out of Tallahassee, Florida and work in collaboration with the Lenhert lab at Florida State University. Lipid Nanotech LLC aim to utilize breakthrough nanointaglio technology to create a strong pipeline of products and services focused on allowing the clinician to screen drug treatment options directly on patient cells.
A critical aspect of precision medicine involves tailoring of medical treatment to the specific characteristics of each patient. Limited patient samples and associated high costs have impeded the application of high throughput platforms to precision medicine.
We will address these issues by employing nanointaglio to fabricate chips of arrays of drugs approved for treatment of specific diseases. The chips which we call LiMiT will be compatible with standard lab subculture and assay techniques and will be used in screening large numbers of drugs directly on patient cell samples. This approach should make personalized medicine widely accessible to most clinicians and provide a useful companion diagnostic and treatment tool for doctors.